You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 15, 2025

List of Excipients in API BUDESONIDE


✉ Email this page to a colleague

« Back to Dashboard


Excipients in NDA-approved (novel) drugs containing BUDESONIDE

Glossary
Company Tradename Ingredient NDC Excipient Potential Generic Entry
AstraZeneca Pharmaceuticals LP PULMICORT budesonide 0186-0916 LACTOSE
AstraZeneca Pharmaceuticals LP PULMICORT RESPULES budesonide 0186-1988 ANHYDROUS CITRIC ACID
AstraZeneca Pharmaceuticals LP PULMICORT RESPULES budesonide 0186-1988 EDETATE DISODIUM
AstraZeneca Pharmaceuticals LP PULMICORT RESPULES budesonide 0186-1988 POLYSORBATE 80
AstraZeneca Pharmaceuticals LP PULMICORT RESPULES budesonide 0186-1988 SODIUM CHLORIDE
AstraZeneca Pharmaceuticals LP PULMICORT RESPULES budesonide 0186-1988 SODIUM CITRATE
>Company >Tradename >Ingredient >NDC >Excipient >Potential Generic Entry

Subscribe to access the full database, or Get Started Free

Excipients in ANDA-approved (generic) drugs containing BUDESONIDE

Company Ingredient NDC Excipient
Teva Pharmaceuticals USA Inc budesonide 0093-6815 CITRIC ACID MONOHYDRATE
Teva Pharmaceuticals USA Inc budesonide 0093-6815 EDETATE DISODIUM
Teva Pharmaceuticals USA Inc budesonide 0093-6815 POLYSORBATE 80
Teva Pharmaceuticals USA Inc budesonide 0093-6815 SODIUM CHLORIDE
Teva Pharmaceuticals USA Inc budesonide 0093-6815 TRISODIUM CITRATE DIHYDRATE
Teva Pharmaceuticals USA Inc budesonide 0093-6815 WATER
>Company >Ingredient >NDC >Excipient

Subscribe to access the full database, or Get Started Free

Detailed excipient profiles for BUDESONIDE

Excipient focus: 1,2-DISTEAROYL-SN-GLYCERO-3-PHOSPHOCHOLINE

Excipient focus: ACESULFAME POTASSIUM

Excipient focus: ACETYLTRIBUTYL CITRATE

Excipient focus: ALCOHOL

Excipient focus: AMMONIA

Excipient focus: AMMONIUM GLYCYRRHIZATE

Excipient focus: ANHYDROUS CITRIC ACID

Excipient focus: ANHYDROUS DEXTROSE

Excipient focus: APAFLURANE

BUDESONIDE drug variants containing APAFLURANE

Company Ingredient NDC
AstraZeneca Pharmaceuticals LP budesonide and formoterol fumarate dihydrate 0186-0370
AstraZeneca Pharmaceuticals LP budesonide and formoterol fumarate dihydrate 0310-7370
Mylan Pharmaceuticals Inc budesonide and formoterol fumarate 0378-7502
A-S Medication Solutions budesonide and formoterol fumarate dihydrate 50090-4508
A-S Medication Solutions budesonide and formoterol fumarate dihydrate 50090-4509
A-S Medication Solutions budesonide and formoterol fumarate dihydrate 50090-4510
>Company >Ingredient >NDC

Subscribe to access the full database, or Get Started Free

Excipient focus: AQUA

Excipient focus: ASCORBIC ACID

Excipient focus: BUTANE

Excipient focus: BUTYL ALCOHOL

Excipient focus: CALCIUM CHLORIDE

Excipient focus: CARBOXYMETHYLCELLULOSE SODIUM

Excipient focus: CELLULOSE, MICROCRYSTALLINE

Excipient focus: CETOSTEARYL ALCOHOL

Excipient focus: CETYL ALCOHOL

Excipient focus: CHERRY

Excipient focus: CITRIC ACID

Excipient focus: CITRIC ACID MONOHYDRATE

Excipient focus: COLLOIDAL SILICON DIOXIDE

Excipient focus: CROSPOVIDONE

Excipient focus: D&C RED NO. 28

Excipient focus: D&C RED NO. 33

Excipient focus: D&C YELLOW NO. 10

Excipient focus: DEXTROSE

Excipient focus: DEXTROSE MONOHYDRATE

Excipient focus: DIBUTYL SEBACATE

Excipient focus: DIMETHICONE

Excipient focus: EDETATE DISODIUM

Excipient focus: ETHYLCELLULOSE

Excipient focus: ETHYLCELLULOSES

Excipient focus: FD&C BLUE NO. 1

Excipient focus: FD&C BLUE NO. 2

Excipient focus: FD&C RED NO. 40

Excipient focus: FD&C YELLOW NO. 6

Excipient focus: FERRIC OXIDE RED

Excipient focus: FERRIC OXIDE YELLOW

Excipient focus: FERROSOFERRIC OXIDE

Excipient focus: GELATIN

Excipient focus: GLYCERIN

Excipient focus: HYDROCHLORIC ACID

Excipient focus: HYDROFLUOROCARBON 227EA

Excipient focus: HYDROXYPROPYL CELLULOSE

Excipient focus: HYPROMELLOSE

Excipient focus: HYPROMELLOSE 2910

Excipient focus: HYPROMELLOSES

Excipient focus: ISOBUTANE

Excipient focus: ISOPROPYL ALCOHOL

Excipient focus: LACTOSE

Excipient focus: LACTOSE MONOHYDRATE

Excipient focus: LECITHIN, SOYBEAN

Excipient focus: MAGNESIUM STEARATE

Excipient focus: MALTODEXTRIN

Excipient focus: MEDIUM-CHAIN TRIGLYCERIDES

Excipient focus: METHACRYLIC ACID

Excipient focus: METHACRYLIC ACID - ETHYL ACRYLATE COPOLYMER

Excipient focus: METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER

Excipient focus: METHACRYLIC ACID AND ETHYL ACRYLATE COPOLYMER

Excipient focus: METHYL ALCOHOL

Excipient focus: MICROCRYSTALLINE CELLULOSE

Excipient focus: MICROCRYSTALLINE CELLULOSE 101

Excipient focus: MICROCRYSTALLINE CELLULOSE 102

Excipient focus: NORFLURANE

Excipient focus: OLEIC ACID

Excipient focus: PEG-20 SORBITAN OLEATE

Excipient focus: POLYDEXTROSE

Excipient focus: POLYETHYLENE GLYCOL

Excipient focus: POLYETHYLENE GLYCOL 1000

BUDESONIDE drug variants containing POLYETHYLENE GLYCOL 1000

Company Ingredient NDC
AstraZeneca Pharmaceuticals LP budesonide and formoterol fumarate dihydrate 0186-0370
AstraZeneca Pharmaceuticals LP budesonide and formoterol fumarate dihydrate 0310-7370
Mylan Pharmaceuticals Inc budesonide and formoterol fumarate 0378-7502
A-S Medication Solutions budesonide and formoterol fumarate dihydrate 50090-1403
A-S Medication Solutions budesonide and formoterol fumarate dihydrate 50090-4508
A-S Medication Solutions budesonide and formoterol fumarate dihydrate 50090-4509
>Company >Ingredient >NDC

Subscribe to access the full database, or Get Started Free

Excipient focus: POLYETHYLENE GLYCOL 400

Excipient focus: POLYETHYLENE GLYCOL 8000

Excipient focus: POLYSORBATE 60

Excipient focus: POLYSORBATE 80

Excipient focus: POTASSIUM HYDROXIDE

Excipient focus: POTASSIUM SORBATE

Excipient focus: POVIDONE K25

BUDESONIDE drug variants containing POVIDONE K25

Company Ingredient NDC
Mylan Pharmaceuticals Inc budesonide and formoterol fumarate 0378-7502
AstraZeneca Pharmaceuticals LP budesonide and formoterol fumarate dihydrate 0186-0370
AstraZeneca Pharmaceuticals LP budesonide and formoterol fumarate dihydrate 0310-7370
A-S Medication Solutions budesonide and formoterol fumarate dihydrate 50090-1403
A-S Medication Solutions budesonide and formoterol fumarate dihydrate 50090-4508
A-S Medication Solutions budesonide and formoterol fumarate dihydrate 50090-4509
>Company >Ingredient >NDC

Subscribe to access the full database, or Get Started Free

Excipient focus: PROPANE

Excipient focus: PROPYLENE GLYCOL

Excipient focus: SHELLAC

Excipient focus: SILICON DIOXIDE

Excipient focus: SODIUM ASCORBATE

Excipient focus: SODIUM BENZOATE

Excipient focus: SODIUM CHLORIDE

Excipient focus: SODIUM CITRATE

Excipient focus: SODIUM HYDROXIDE

Excipient focus: SODIUM LAURYL SULFATE

Excipient focus: SODIUM STARCH GLYCOLATE TYPE A POTATO

Excipient focus: SOYBEAN LECITHIN

Excipient focus: STARCH, CORN

Excipient focus: STEARETH-10

Excipient focus: STEARIC ACID

Excipient focus: SUCROSE

Excipient focus: TALC

Excipient focus: TITANIUM DIOXIDE

Excipient focus: TRIACETIN

Excipient focus: TRIETHYL CITRATE

Excipient focus: TRISODIUM CITRATE

Excipient focus: TRISODIUM CITRATE DIHYDRATE

Excipient focus: WATER

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

 
© Copyright 2002-2025 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2025 - 2026
 NCE-1 Patent Challenge Dates 2025 - 2026
Preferred Citation:

Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2025, www.DrugPatentWatch.com.
   See Primary Research Papers Citing DrugPatentWatch

Links